HeartBeat.bio raises € 4.5 million in Pre-Series A financing
New funds to drive development of organoid screening platform for cardiac drug discovery
03-Nov-2023 -
HeartBeat.bio AG, a biotech company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease, announced the closing of a € 4.5 million Pre-Series A round co-led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures. The financing ...
artificial intelligence
cardiovascular diseases
drug development
+4